Engagement Recognized for Strong Partnership, Business Achievement, People Practices, and Customer Dedication
NEW YORK, July 11, 2012 /PRNewswire/ -- Genpact Limited (NYSE: G), a global leader in business process and technology management, today announced that it has recently received two prestigious industry awards in conjunction with its client AstraZeneca. The Outsourcing Center, as part of its 2012 Outsourcing Excellence Awards, presented the award for "Best F&A/Procurement" engagement to Genpact and AstraZeneca. In addition, the Shared Services Outsourcing Network (SSON) awarded Genpact and AstraZeneca for "Excellence in People and Communication" at their 2012 Excellence Awards ceremony in Amsterdam.
Over the past three years, Genpact and AstraZeneca have enjoyed a very strong working partnership, enabling a seamless transition of extensive finance and accounting (F&A) services across more than 40 markets in multiple regions including Latin America and Europe. Genpact's engagement scope has also expanded to include diverse services such as learning and marketing solutions, supplier research, spend analytics, and process reengineering. Genpact is also supporting AstraZeneca in their global finance process transformation roadmap to take AstraZeneca's finance operations to best-in-class in the pharmaceutical industry.
The Genpact-AstraZeneca engagement has resulted in significant business outcomes for AstraZeneca's operations to date. These include: the standardization of processes and increased visibility on metrics across F&A transactional processes from the outset; the ability to expand in high growth markets; measureable reductions in the cost of transactional F&A processes; and deployment of efficiency enhancing tools to enable the automation of finance processes and enhancement of customer satisfaction.
"Genpact is extremely proud of the work we do with AstraZeneca and we are honored to receive these awards from the Outsourcing Center and SSON," said Balkrishan 'BK' Kalra, senior vice president and business leader, Life Sciences at Genpact. "The business impact that we have helped AstraZeneca achieve to date is a product of the incredibly collaborative and open partnership that we have and the joint commitment to meeting and exceeding AstraZeneca's business goals."
The Outsourcing Center's Outsourcing Excellence Award winners were judged by an independent panel of industry experts who evaluated numerous worldwide outsourcing relationships. SSON's annual Shared Services Excellence Awards honor, recognize and promote both captive and outsourced shared services that demonstrate winning practices, forming the industry benchmark in terms of performance excellence.
Genpact Limited (NYSE: G), a global leader in business process and technology management services, leverages the power of smarter processes, smarter analytics and smarter technology to help its clients drive intelligence across their enterprise. Genpact's Smart Enterprise Processes (SEPSM) framework, its unique science of process combined with deep domain expertise in multiple industry verticals, leads to superior business outcomes. Genpact's Smart Decision Services deliver valuable business insights to its clients through targeted analytics, reengineering expertise, and advanced risk management. Making technology more intelligent by embedding it with process and data insights, Genpact also offers a wide range of technology services. Driven by a passion for process innovation and operational excellence built on its Lean and Six Sigma DNA and the legacy of serving GE for more than 15 years, the company's 56,000+ professionals around the globe deliver services to its more than 600 clients from a network of 67 delivery centers across 18 countries supporting more than 30 languages. For more information, visit www.genpact.com. Follow Genpact on Twitter, Facebook and LinkedIn.
For more information:
Gail Marold (Genpact Media Relations)
Barbara Tate (For Genpact U.S.)
Rupali Kathuria (For Genpact India)
SOURCE Genpact Limited